4.7 Article

Disruption of protein phosphatase 1 complexes with the use of bioportides as a novel approach to target sperm motility

Journal

FERTILITY AND STERILITY
Volume 115, Issue 2, Pages 348-362

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2020.08.013

Keywords

Sperm motility; male contraception; protein-protein interactions; protein phosphatase 1; PP1-disrupting peptides

Funding

  1. Fundo Europeu de Desenvolvimento Regional funds through the Programa Operacional Competitividade e Internacionalizacao COMPETE 2020
  2. Fundacao para a Ciencia e Tecnologia [PTDB/BBB-BQB/3804/2014, SFRH/BPD/123155/2016]
  3. iBiMED [UIDB/04501/2020, POCI-01-0145FEDER-007628]
  4. Fundação para a Ciência e a Tecnologia [SFRH/BPD/123155/2016] Funding Source: FCT

Ask authors/readers for more resources

By designing bioportides with targeting PP1 disrupting function, the sperm vitality and motility were significantly affected, providing a new research approach for predicting male fertility indicators.
Objective: To design protein phosphatase 1 (PP1)-disrupting peptides covalently coupled to inert cell-penetrating peptides (CPPs) as sychnologically organized bioportide constructs as a strategy to modulate sperm motility. Design: Experimental study. Setting: Academic research laboratory. Patient(s)/Animal(s): Normozoospermic men providing samples for routine analysis and Holstein Frisian bulls. Intervention(s): None. Main Outcome Measure(s): Effect of the bioportides on the activity and interactions of PP1 gamma 2-a PP1 isoform expressed exclusively in testicular germ cells and sperm-and on sperm vitality and motility. Result(s): PP1-disrupting peptides were designed based on the sequences from: 1) a sperm-specific PP1 interactor (A kinase anchor protein 4); and 2) a PP1 inhibitor (protein phosphatase inhibitor 2). Those sequences were covalently coupled to inert CPPs as bioportide constructs, which were successfully delivered to the flagellum of sperm cells to induce a marked impact on PP1 gamma 2 activity and sperm motility. Molecular modeling studies further facilitated the identification of an optimized PP1-binding sequence and enabled the development of a modified stop-sperm bioportide with reduced size and increased potency of action. In addition, a bioportide mimetic of the unique 22-amino acid C-terminus of PP1 gamma 2 accumulated within spermatozoa to significantly reduce sperm motility and further define the PP1 gamma 2-specific interactome. Conclusion(s): These investigations demonstrate the utility of CPPs to deliver peptide sequences that target unique protein-protein interactions in spermatozoa to achieve a significant impact upon spermatozoa motility, a key prognostic indicator of male fertility. (C) 2020 by American Society for Reproductive Medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available